PriceFind
Back
Identification of Biomarkers, New Treatments, and Vaccines for Covid-19
BooksTakealot

Identification of Biomarkers, New Treatments, and Vaccines for Covid-19

R 6 999.00

Takealot · checked 16 days ago

View at Takealot

25 offers · 3 retailers

Listed under the same model number

No barcode ties these listings together, so no saving is claimed. See the listings

Matched by model number; no shared barcode

Average
R 6 999.00
Lowest seen
R 6 999.00
Highest seen
R 6 999.00
Last change
R 0.00
First indexed
22 Oct 2026
Retailer
Takealot

Each price is from PriceFind's last check of that retailer. Follow the link for the live price.

Description

The novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just one year. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as diabetes and obesity. As the cases and death rate remain high, there are justified fears of this virus remaining for several months or years to come. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these begin to be deployed and administered across the globe, many now feel the virus will be brought under control and lives will eventually return to normal.

This new volume will increase readers' understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.

Similar products

Identification of Circulating Biomarkers for Diagnosis and Response to Therapies in Cancer Patients Part A: Volume 391

Takealot

Identification of Circulating Biomarkers for Diagnosis and Response to Therapies in Cancer Patients Part A: Volume 391

R 7 130.00